Huib N. Caron
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 85 publications
MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastoma.
Journal: Frontiers in oncology
Published: December 22, 2022
SLC7A8 coding for LAT2 is associated with early disease progression in osteosarcoma and transports doxorubicin.
Journal: Frontiers in pharmacology
Published: September 13, 2022
Genome-wide analyses of platinum-induced ototoxicity in childhood cancer patients: Results of GO-CAT and United Kingdom MAGIC consortia.
Journal: Frontiers in pharmacology
Published: June 28, 2022
Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 09, 2020
International Consensus on Minimum Preclinical Testing Requirements for the Development of Innovative Therapies For Children and Adolescents with Cancer.
Journal: Molecular cancer therapeutics
Published: May 10, 2020
Mesenchymal Neuroblastoma Cells Are Undetected by Current mRNA Marker Panels: The Development of a Specific Neuroblastoma Mesenchymal Minimal Residual Disease Panel.
Journal: JCO precision oncology
Published: September 10, 2019
Psychosocial well-being of long-term survivors of pediatric head-neck rhabdomyosarcoma.
Journal: Pediatric blood & cancer
Published: June 19, 2018
Peripheral Stem Cell Apheresis is Feasible Post 131Iodine-Metaiodobenzylguanidine-Therapy in High-Risk Neuroblastoma, but Results in Delayed Platelet Reconstitution.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 15, 2018
3-Methoxytyramine: An independent prognostic biomarker that associates with high-risk disease and poor clinical outcome in neuroblastoma patients.
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 08, 2017
Asparaginase inhibits the lectin pathway of complement activation.
Journal: Molecular immunology
Published: August 30, 2017
Facial asymmetry in head and neck rhabdomyosarcoma survivors.
Journal: Pediatric blood & cancer
Published: October 27, 2016
Enhancer of zeste homologue 2 plays an important role in neuroblastoma cell survival independent of its histone methyltransferase activity.
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 13, 2016
Last Updated: 09/26/2026